RGFX

RGFX is a study-specific **compound dietary-fiber prebiotic preparation** evaluated by West China Hospital of Sichuan University as an adjunctive intervention for adults with refractory epilepsy. It was listed alongside the probiotic product Peifeikang in the phase 1 ChiCTR2100051328 trial, which sought to reduce seizure frequency, improve adverse effects associated with conventional antiseizure medicines, improve quality of life, and assess inflammatory-factor and neurotransmitter changes. The registry identifies the study as investigator-discontinued; RGFX's exact fiber composition, dose, dosage form, manufacturer, and molecular mechanism have not been publicly disclosed. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=132689))

Other names

compound dietary fiber RGFXRGFX复合膳食纤维RGFX